Clinical Trials Directory

Trials / Unknown

UnknownNCT00452296

Tight Glycemic Control in Acute Exacerbations of COPD

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
45 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Glucose control has been shown as an important and independent prognostic factor in several acute conditions in hospitalized patients, including Acute MI, stroke, cardiac surgery and in critical care units. Patients with acute exacerbation of COPD (AECOPD)and diabetes treated with insulin had a longer in-patient stay and more frequent isolation of Gram negative bacteria from sputum than those without diabetes.Hyperglycemia (\>11 mmol/l) on admission predicted failure of non-invasive ventilation and infectious pulmonary complications in patients admitted to the ICU with acute respiratory failure caused by severe AECOPD. The primary goal of this study is to test the hypothesis that in AECOPD, tight glycemic control during hospital stay will improve outcome of hospitalization. The secondary goal of this study is to test new ways in controlling patients in the internal medicine ward.

Conditions

Interventions

TypeNameDescription
DRUGtight insulin treatment in patients hospitalized with COPD exacerbationtreatment with basal plus bolus insulin
PROCEDUREtight glycemic controltreatment with basal and bolus insulin

Timeline

Start date
2007-04-01
Primary completion
2010-05-01
Completion
2012-12-01
First posted
2007-03-27
Last updated
2012-06-26

Source: ClinicalTrials.gov record NCT00452296. Inclusion in this directory is not an endorsement.